The good newsfor all customers is here, the costs of the generic drugs are fallingworldwide. The global economical crises and the competition from the brand drugmanufacturers had lead to the decline in the costs of the generic drugs. Thecompetitions among the generic drug manufacturers have also lead a considerableeffect on the costs of the generic drug. The decrease in costs of generic drugsis observed to be about 10% to 15%. In United States the decline in the prizes of thegeneric drugs is observed to be about 25% because of the ultra-low prices forgeneric prescriptions offered by giant retailers and drugstore chains andintense competition among the many generic drug-makers fighting for sales.Another important reason for the decline in the costs of the generic drugs isthe reduction in the cost of the branded drugs. So, to remain in competitiongeneric drug manufacturer has to decrease the costs of the generic drugs.

Generic drugssale is also hit by the global economical crises. Customers used to usually buythe full strip of the medicines even doctor has prescribed them 6 or 8 tablets.But, now customers are specifically asking for only the number of pills thatare prescribed by the doctors. No customer is okay with the purchasing of theextra pills. This has lead to the loss of the whole-sellers as well as of thegeneric drug manufacturers. Global economic crises has hit the branded drugsbadly and to minimize lose the branded drug manufacturer have even reduced theprices of the drugs. This phenomena lead to the competition between the genericdrugs and branded drugs. So, to remain in market generic drug manufacturer haveto reduce the prices of their drugs. Some generic drug manufacturers have tonow keep the policy of ?no profit no loss? to match their prices with the othergeneric drugs in the market.

Drug supplierswere selling the branded drugs in bulk to the customers and thus branded drugsalso became quit cheap like the generic drugs. This was the special policybrought up by the branded drug manufacturers to cope with the lowering economy.But, this policy affected the sale of generic drugs to great extent. Thus, tocope with this policy, even generic drug manufacturers have to reduce theprizes of the drugs. Those pricing pressures forced down dollar sales ofgeneric drugs in the U.S.by 2.7 percent in the year ending in September, even though the number ofgeneric prescriptions filled actually increased by 5.4 percent over the yearbefore. This point clearly mentions that the global economic crises haveaffected the generic drug sales adversely.

The sale ofgeneric drugs is found to be increased in the European markets in comparison tothe last year, but the profits earned by the generic drug manufacturers arereduced as they have to cope up with the competition given by the brandeddrugs. Even the doctors from the European countries are still not sure aboutthe quality of the generic drugs, so still are sticking with the prescriptionsof the branded drugs. Thus, the customers have to ask to the drug supplier forthe generic drugs. But, in spite of this generic drugs have managed to get themaximum sale in the European countries because of the excellent quality andlowest possible price.

The main reasonfor the cost cutting in the generic drugs is the availability of the lots ofthe generic drugs in the market, for Viagra alone the generic versionsavailable in the market are Penegra, Kamagra, Zenegra, Silagra, etc. Thus dueto the competition among the generic drug manufacturer, the costs of thegeneric drugs are reduced. More brand-name companies are trying to compensatefor slow growth are making their own generics to cope up with the economicalinstability. The markets all over the world are facing the economical crises,and thus have to reduce the costs of the generic drugs.